Last update: : 10.02.2025
Our Research The D170 Microenvironment Team focuses on identification of immunotherapeutic targets within the central nervous system microenvironment with the goal to enhance the reactivity of the…
Last update: : 10.02.2025
Our Research Teamleader: Theresa Bunse, PhD Despite a strict control of immune processes in the central nervous system (CNS), CNS immunity is off balance during autoimmune diseases and in CNS…
Last update: : 10.02.2025
Our Research The immune monitoring unit is located at the NCT and analyzes samples from cancer patients of various entities enrolled in clinical trials. We are specialized in monitoring antigen…
Last update: : 10.02.2025
Head of Department Administrative Assistant Postdoctoral Fellows PhD Students Research Technician Students
Last update: : 10.02.2025
Dr. Haikun Liu +49 6221 42 3266 +49 6221 42 3259 A240 Head of Division I was born in 1978 and began my academic journey studying biology at Shandong Normal University in China. From there, I moved…
Last update: : 10.02.2025
The Radiotracer group is currently working on the following topics: Establishment of GMP compliant production and quality control The working group has a long-standing expertise in the GMP…
Last update: : 10.02.2025
The "Radiopharmaceuticals" working group of the "Radiopharmaceuticals and Preclinical Studies" sevice unit is focusing on the development and optimization of radiopharmaceuticals for preclinical…
Last update: : 10.02.2025
Radioisotope production is an interdisciplinary field comprising the amalgam of science and engineering. The 'Cyclotron and Target Development' group at DKFZ utilizes this blend to focus on…
Last update: : 10.02.2025
Morszeck Preclinical Trial Unit (PCTU) Radiotracer Unit Radiopharmaceuticals Cyclotron and Target Development Unit. In addition to imaging and irradiation design/irradiation for preclinical…
Last update: : 07.02.2025
A research team from the Heidelberg Medical Faculty, the German Cancer Research Center (DKFZ) and the Berlin Institute of Health at Charité (BIH) has gained significant insights into the progression…
Press release